IMMUNOGEN, INC.

Patent Owner

Compare
4Status Updates

Stats

Details

Technologies

Intl Class Technology # of Patents Rank
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 52155
 
 
 
C07D HETEROCYCLIC COMPOUNDS 2896
 
 
 
C07K PEPTIDES 1771
 
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 868
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 782
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 538
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 4124
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 4134
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 273
 
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 2105

Top Patents (by citation)

Upgrade to the Premium Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2014/0099,308 Novel EGFR-Binding Molecules and Immunoconjugates ThereofMar 13, 13Apr 10, 14[A61K, C07K]
2014/0093,523 Anti-Integrin Immunoconjugates, Methods and UsesDec 04, 13Apr 03, 14[A61K]
2014/0088,089 CYTOTOXIC BENZODIAZEPINE DERIVATIVES AND METHODS OF PREPARATIONFeb 15, 12Mar 27, 14[C07D, A61K]
2014/0023,662 NON-ANTAGONISTIC EGFR-BINDING MOLECULES AND IMMUNOCONJUGATES THEREOFOct 28, 11Jan 23, 14[A61K, G01N, C07K]
2014/0023,665 NOVEL MAYTANSINOID DERIVATIVES WITH SULFOXIDE LINKERMar 20, 12Jan 23, 14[C07D, A61K]
2014/0010,828 USES OF IMMUNOCONJUGATES TARGETING CD138Dec 07, 12Jan 09, 14[A61K]
2013/0323,268 CYTOTOXIC AGENTS COMPRISING NEW ANSAMITOCIN DERIVATIVESNov 03, 11Dec 05, 13[C07D, A61K]
2013/0295,050 ANTI-IGF-I RECEPTOR ANTIBODIES, DNAS, VECTORS, HOST CELLS AND GENETIC CONSTRUCTSSep 14, 12Nov 07, 13[A61K]
2013/0156,796 Method of Treatment of Tumors That Are Resistant to EGFR Therapies by EGFR Antibody Cytotoxic Agent ConjugateNov 21, 12Jun 20, 13[A61K]
2013/0108,620 METHODS OF TREATMENT USING ANTI-ERBB ANTIBODY-MAYTANSINOID CONJUGATESNov 28, 11May 02, 13[A61K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8,685,920 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugatesJul 08, 11Apr 01, 14[C07D]
RE44704 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agentsSep 13, 12Jan 14, 14[A61K]
8,624,003 Methods for preparation of antibody-maytansinoid conjugatesJun 03, 10Jan 07, 14[A61K, C07K]
8,613,930 Cross-linkers and their usesJul 05, 12Dec 24, 13[A61K, C07K]
8,603,483 Anti-integrin immunoconjugates, methods and usesNov 30, 05Dec 10, 13[A61K, C07K]
8,598,362 Methods for the preparation of charged crosslinkersDec 08, 11Dec 03, 13[C07D]
8,563,509 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugatesOct 29, 07Oct 22, 13[C07D]
8,563,700 Synergistic effectsJun 16, 09Oct 22, 13[A61K, C07K]
8,557,966 Folate receptor 1 antibodies and immunoconjugates and uses thereofFeb 24, 11Oct 15, 13[C12P, C07K]
8,435,528 Cytotoxic agents comprising new maytansinoidsJul 16, 07May 07, 13[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Filing Date Issue/Pub Date Intl Class
8,093,358 Methods of treatment using anti-erbb antibody-maytansinoid conjugatesDec 03, 07Jan 10, 12[C07K]
2011/0008,373 PRODRUGS OF CC-1065 ANALOGSSep 20, 10Jan 13, 11[C07F, C07D, A61P, A61K, C07K]
2010/0260,678 ANTI-IGF-I RECEPTOR ANTIBODIESApr 30, 10Oct 14, 10[A61P, A61K]
2010/0136,033 METHODS OF TREATMENT USING ANTI-ErbB ANTIBODY-MAYTANSINOID CONJUGATESOct 30, 09Jun 03, 10[A61P, A61K, C07K]
2010/0092,495 POTENT CELL-BINDING AGENT DRUG CONJUGATESOct 06, 09Apr 15, 10[A61P, A61K, C07K]
2009/0291,090 ANTI-CD33 ANTIBODIES AND METHOD FOR TREATMENT OF ACUTE MYELOID LEUKEMIA USING THE SAMEJan 23, 09Nov 26, 09[C12N, C12P, G01N, A61K, C07K]
2009/0162,284 ANTI-IGF-I RECEPTOR ANTIBODYOct 15, 08Jun 25, 09[C12N, A61K, C07K]
7,449,450 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene productsApr 13, 05Nov 11, 08[A61K]
2008/0167,458 ANTI-CD33 ANTIBODIES AND METHOD FOR TREATMENT OF ACUTE MYELOID LEUKEMIA USING THE SAMEDec 20, 07Jul 10, 08[C07H]
2008/0138,898 METHODS FOR IMPROVING ANTIBODY PRODUCTIONOct 30, 07Jun 12, 08[C12N, C07H, C07K]
7,358,088 Peptides and compositions which modulate apoptosisAug 10, 06Apr 15, 08[A61K]
2006/0233,814 Elimination of heterogeneous or mixed cell population in tumorsApr 14, 06Oct 19, 06[A61K, C07K]
2006/0182,750 Process for preparing stable drug conjugatesFeb 10, 06Aug 17, 06[A61K, C07K]
2005/0249,728 Anti-IGF-I receptor antibodySep 02, 04Nov 10, 05[A61K]
2005/0186,203 Anti-IGF-I receptor antibodyJul 23, 04Aug 25, 05[A61K, C07K]
2005/0123,549 CA6 antigen-specific cytotoxic conjugate and methods of using the sameJul 21, 04Jun 09, 05[C12N, C12P, A61K]
6,057,132 Nucleotide sequences encoding apoptosis associated Bbk proteinNov 09, 98May 02, 00[C12N, C12P]
5,239,062 Blocked lectins, methods and affinity support for making same using affinity ligands, and method of killing selected cell populations having reduced nonselective cytotoxicityJul 31, 90Aug 24, 93[A61K, C07K]

Top Inventors for This Owner

Upgrade to the Premium Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!